Capital Fund Management (CFM)’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Hold |
0
| – | – | – | 1029 |
|
|
2019
Q3 | – | Sell |
-3,334
| Closed | -$237K | – | 918 |
|
|
2019
Q2 | $237K | Buy |
+3,334
| New | +$237K | ﹤0.01% | 632 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 998 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 1014 |
|
|
2018
Q3 | – | Sell |
-4,716
| Closed | -$609K | – | 1047 |
|
|
2018
Q2 | $609K | Buy |
4,716
+1,895
| +67% | +$245K | ﹤0.01% | 664 |
|
|
2018
Q1 | $291K | Buy |
+2,821
| New | +$291K | ﹤0.01% | 755 |
|
|
2017
Q2 | – | Sell |
-10,104
| Closed | -$667K | – | 934 |
|
|
2017
Q1 | $667K | Sell |
10,104
-15,780
| -61% | -$1.04M | 0.01% | 640 |
|
|
2016
Q4 | $1.64M | Sell |
25,884
-243
| -0.9% | -$15.4K | 0.01% | 464 |
|
|
2016
Q3 | $1.66M | Buy |
26,127
+18,678
| +251% | +$1.19M | 0.02% | 444 |
|
|
2016
Q2 | $554K | Buy |
+7,449
| New | +$554K | 0.01% | 634 |
|
|
2015
Q3 | – | Sell |
-5,290
| Closed | -$333K | – | 803 |
|
|
2015
Q2 | $333K | Buy |
+5,290
| New | +$333K | ﹤0.01% | 542 |
|
|
2014
Q4 | – | Sell |
-38,151
| Closed | -$1.12M | – | 855 |
|
|
2014
Q3 | $1.12M | Buy |
+38,151
| New | +$1.12M | 0.01% | 365 |
|